Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × dostarlimab × 90 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Neoplasms 3 Colonic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 1 Neuroblastoma 1 Neoplasm Metastasis 1 Locally Advanced Rectal Cancer (LARC) 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Brain Neoplasms 1 Bites and Stings 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡